Incidence of cerebral hemorrhage after antifibrinolytic treatment for embolic stroke in rabbits

P. D. Lyden, K. P. Madden, W. M. Clark, K. C. Sasse, J. A. Zivin

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Abstract

We studied thrombolysis in an animal model of embolic stroke to determine the safety of tissue plasminogen activator and streptokinase. We occluded the middle cerebral arteries of 137 rabbits with radiolabeled blood clots and administered tissue plasminogen activator (n=49), streptokinase (n=40), or saline (n=48) at various times after embolization. We assessed the rate of thrombolysis and cerebral hemorrhage 24 hours later. Both drugs were very effective in producing thrombolysis. Compared with saline, streptokinase caused a significant increase in the rate of cerebral hemorrhage (p<0.05), but tissue plasminogen activator did not. We conclude that thrombolytic therapy for acute stroke should be safer with tissue plasminogen activator than with streptokinase.

Original languageEnglish (US)
Pages (from-to)1589-1593
Number of pages5
JournalStroke
Volume21
Issue number11
DOIs
StatePublished - Nov 1990

Keywords

  • Antifibrinolytic agents
  • Cerebral hemorrhage
  • Embolism
  • Rabbits

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Incidence of cerebral hemorrhage after antifibrinolytic treatment for embolic stroke in rabbits'. Together they form a unique fingerprint.

Cite this